Skip to main content
logo
Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
24.57
-0.36 (-1.44%)
At close: Aug 26, 2026, 4:00 PM EDT
24.35
-0.22 (-0.90%)
After-hours: Aug 26, 2026, 5:20 PM EDT

Denali Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-511.45-512.54-422.77-145.22-325.99-290.58
Depreciation & Amortization
15.8914.818.998.8310.388.59
Loss (Gain) From Sale of Assets
---14.54---
Asset Writedown & Restructuring Costs
---7.9--
Loss (Gain) From Sale of Investments
-6.37-10.25-35.12-43.95-1.648.75
Stock-Based Compensation
95.0999.63102.88108.199.8585.25
Other Operating Activities
1.13-4.4-4.07-3.72-3.29-2.98
Change in Accounts Payable
-3.38-7.521.442.432.273.71
Change in Unearned Revenue
----290.53-34.46-15.66
Change in Other Net Operating Assets
-16.887.6715.5-1.838.16-8.46
Operating Cash Flow
-434.04-412.6-347.69-357.99-244.72-211.39
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3.42-9.5-15.91-12.94-17.83-8.5
Investment in Securities
101.2264.78-72.84262.25-123.55-13.13
Investing Cash Flow
68.98255.28-88.76249.31-141.39-21.63

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--8.17-32.34---
Net Debt Issued (Repaid)
-1.42-8.17-32.34---
Issuance of Common Stock
955.12925.71517.1217.82311.7319.35
Other Financing Activities
-528.32-728.32-0.48--1.06-
Financing Cash Flow
425.38189.22484.317.82310.6719.35

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
60.3231.947.85-90.86-75.43-213.67

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-437.46-422.1-363.61-370.93-262.55-219.89
Free Cash Flow Growth
------
Free Cash Flow Margin
-12138.10%---112.22%-242.06%-451.88%
Free Cash Flow Per Share
-2.42-2.44-2.21-2.70-2.09-1.81
Levered Free Cash Flow
-268.53-244.19-200.74-298.35-141.03200.41
Unlevered Free Cash Flow
-268.53-244.19-200.74-298.35-141.03200.41

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.720.720.3---
Cash Income Tax Paid
0.050.05-00.050.21
Change in Working Capital
-28.320.1516.94-289.93-24.03-20.41
SEC Filings: 10-K · 10-Q